Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn:
“Excited to arrive in Miami for the Baptist Health Miami Cancer Institute Precision Oncology Symposium!
Honored to deliver the keynote.
“Re-imagining the (R)evolution in the Precision Oncology Paradigm”.
Incredible line up of keynote speakers – Julie Gralow, American Society of Clinical Oncology (ASCO), Luis Diaz, Memorial Sloan Kettering Cancer Center & amazing rockstar speakers.
Huge thanks to Dr. Manmeet Ahluwalia, for leading an inspiring agenda!
